Name: UMIN ID:
Unique ID issued by UMIN | UMIN000019477 |
---|---|
Receipt number | R000022229 |
Scientific Title | A study on sarcopenia induced by anti-cancer molecular targeted agents |
Date of disclosure of the study information | 2015/10/23 |
Last modified on | 2023/04/30 21:24:50 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/10/23 18:02:38 | ||
2 | Update | 2015/10/28 20:01:33 | Other related information Other related information |
|
3 | Update | 2016/12/04 15:16:34 | Name of primary person or sponsor Organization Category of Funding Organization |
|
4 | Update | 2016/12/04 15:17:27 | Other related information |
|
5 | Update | 2018/04/25 12:17:28 | Last follow-up date Other related information Other related information |
|
6 | Update | 2018/04/25 12:17:59 | Recruitment status |
|
7 | Update | 2018/10/25 19:52:56 | Other related information Other related information |
|
8 | Update | 2019/10/29 13:21:32 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Email3 Organization Organization Address Address Tel |
|
9 | Update | 2019/10/29 13:30:49 | Date of IRB Last follow-up date |
|
10 | Update | 2019/10/29 13:31:45 | Number of participants that the trial has enrolled |
|
11 | Update | 2020/04/26 17:04:25 | Last follow-up date |
|
12 | Update | 2021/04/27 16:10:13 | Last follow-up date |
|
13 | Update | 2022/04/28 15:39:22 | Last follow-up date |
|
14 | Update | 2022/10/28 09:35:30 | Other related information |
|
15 | Update | 2023/04/30 21:24:50 | Last follow-up date |